Alterola Biotech Inc (OTCMKTS:ALTA) Director Jr. Fred W. Fairclough sold 3,750 shares of the business’s stock in a transaction dated Wednesday, July 29th. The shares were sold at an average price of $20.26, for a total transaction of $75,975.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.
Shares of ALTA stock opened at $18.75 on Friday. The company has a 50-day moving average price of $12.70. Alterola Biotech Inc has a twelve month low of $13.55 and a twelve month high of $31.27.
Alterola Biotech (OTCMKTS:ALTA) last issued its earnings results on Wednesday, July 29th. The company reported $0.55 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.47 by $0.08. The firm had revenue of $31.91 million for the quarter, compared to analysts’ expectations of $30.39 million.
The business also recently declared a quarterly dividend, which will be paid on Monday, August 17th. Investors of record on Monday, August 10th will be given a dividend of $0.13 per share. This represents a $0.52 annualized dividend and a yield of 2.77%. The ex-dividend date of this dividend is Friday, August 7th.
About Alterola Biotech
Alterola Biotech, Inc, a development stage company, focuses on the development of nutrition and health chewing gums with natural based ingredients in the United States. Its products under development include appetite suppressors, cholesterol suppressors, antioxidant gums, motion sickness suppressors, and vitamin gums.
Further Reading: Oversold
Receive News & Ratings for Alterola Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alterola Biotech and related companies with MarketBeat.com's FREE daily email newsletter.